Market Cap 829.86M
Revenue (ttm) 76.99M
Net Income (ttm) -174.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.74%
Debt to Equity Ratio 0.48
Volume 13,268,300
Avg Vol 8,198,090
Day's Range N/A - N/A
Shares Out 638.36M
Stochastic %K 14%
Beta 0.59
Analysts Sell
Price Target $3.33

Company Profile

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 473 7700
Address:
919 East Hillsdale Boulevard, Suite 250, Foster City, United States
ZoeyTanner
ZoeyTanner Jan. 17 at 3:39 PM
$GERN I dare say, that there are a select few retail around since 2018 still holding 6 pps gern. With dollar cost averaging, many may have the 3's with moving tranche dollars into portfolio. Blind justice would be 3 dollar BO, but not make anybody whole. Many more have since passed, or decided enough is enough. Divorce, illness, or finally just got old. The life of geron survivor
0 · Reply
Tacto
Tacto Jan. 17 at 12:46 AM
$GERN Volume today was around double the daily average, but the vast bulk of today's volume was done in four off-exchange, supremely bogus transactions, with 2M at 12:39pm, 3.7M at 3:39pm, 3.7M at 3:42pm, and 3.7M at 3:52pm Those crime syndicate operators can't seem to inject any creativity in their distortion scheme, but I guess they don't have to, since the authorities aren't paying a lick of attention to what they're doing, even though their Geron stock-dorking program is on quite a grand scale. "Gee, fellas, let's just do the 3.7M thing over and over again, what the hell" Goons aren't terribly bright, but they are willing to trample on all the rules, with great impunity . .
1 · Reply
Tacto
Tacto Jan. 17 at 12:12 AM
$GERN New Geron corporate presentation just out today. https://s201.q4cdn.com/710325604/files/doc_presentations/2026/Jan/12/Geron-Corporate-Deck-January-2026_FINAL2-1-12-26.pdf Maybe the Europe partnership deal is done, and they're just wrapping up the fine details before making an announcement, otherwise it seems highly unlikely that it wouldn't be mentioned in this presentation... . .
1 · Reply
Tacto
Tacto Jan. 16 at 10:46 PM
$GERN Yup, Aberdeen increased their stake by 60% in Q4, and their estimated average cost per share is $2.11
1 · Reply
smar312
smar312 Jan. 16 at 9:23 PM
$GERN Aberdeen Group just increased share ownership by over 3.5 million. They now hold over 9.5 million shares.
0 · Reply
Srinivas111
Srinivas111 Jan. 16 at 8:44 PM
0 · Reply
ZoeyTanner
ZoeyTanner Jan. 16 at 4:22 PM
$GERN Never hold gains. Investors get tired of excuses and just want out
2 · Reply
foghornL
foghornL Jan. 16 at 3:43 PM
1 · Reply
Tacto
Tacto Jan. 16 at 11:52 AM
$GERN Retail has a minuscule stake, so those stock-dorking idiots can't cover even a tiny fraction of their 70M standard shorts by wresting even the totality of what retail holds, let alone the colossal mass of abusive-naked shorts (counterfeits) they've introduced into the float and are responsible for making good on, and for which they stand to lose their collateral, so they're pretty well f'd, and they know it better than anyone, and it's just a matter of time before they get blown up. Plus, you can bet that I'm not the only retail type whose pocket those assholes can't pick. They've been selling millions of shares to themselves every day, to suppress the stock to delay their demise, but that's just treading water, and they'll soon have to to buy genuine shares on the open market, which will spark a BIG SQUEEZE and cost those ass-clowns several times the utterly-retarded and totally manufactured price you see today. This is the game, and I've got the time, so I'll see it through
1 · Reply
afc2881
afc2881 Jan. 16 at 2:16 AM
$GERN https://www.nature.com/articles/s41375-025-02831-z
0 · Reply
Latest News on GERN
Geron Corporation Provides 2026 Financial Guidance

Jan 12, 2026, 8:00 AM EST - 5 days ago

Geron Corporation Provides 2026 Financial Guidance


Geron Corporation (GERN) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 2:21 PM EST - 2 months ago

Geron Corporation (GERN) Q3 2025 Earnings Call Transcript


Geron Corporation to Present at Upcoming Investor Conferences

Nov 4, 2025, 8:00 AM EST - 2 months ago

Geron Corporation to Present at Upcoming Investor Conferences


Making Money In Biotech Stocks

Oct 9, 2025, 5:00 PM EDT - 3 months ago

Making Money In Biotech Stocks

SNDX


Geron: I Think We've Seen This Movie Before

Aug 8, 2025, 9:30 AM EDT - 5 months ago

Geron: I Think We've Seen This Movie Before


Geron Corporation (GERN) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:01 PM EDT - 5 months ago

Geron Corporation (GERN) Q2 2025 Earnings Call Transcript


Conservative Vision Of A Positive Future For Geron

Jun 3, 2025, 9:57 AM EDT - 8 months ago

Conservative Vision Of A Positive Future For Geron


Geron Corporation (GERN) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:50 PM EDT - 9 months ago

Geron Corporation (GERN) Q1 2025 Earnings Call Transcript


ZoeyTanner
ZoeyTanner Jan. 17 at 3:39 PM
$GERN I dare say, that there are a select few retail around since 2018 still holding 6 pps gern. With dollar cost averaging, many may have the 3's with moving tranche dollars into portfolio. Blind justice would be 3 dollar BO, but not make anybody whole. Many more have since passed, or decided enough is enough. Divorce, illness, or finally just got old. The life of geron survivor
0 · Reply
Tacto
Tacto Jan. 17 at 12:46 AM
$GERN Volume today was around double the daily average, but the vast bulk of today's volume was done in four off-exchange, supremely bogus transactions, with 2M at 12:39pm, 3.7M at 3:39pm, 3.7M at 3:42pm, and 3.7M at 3:52pm Those crime syndicate operators can't seem to inject any creativity in their distortion scheme, but I guess they don't have to, since the authorities aren't paying a lick of attention to what they're doing, even though their Geron stock-dorking program is on quite a grand scale. "Gee, fellas, let's just do the 3.7M thing over and over again, what the hell" Goons aren't terribly bright, but they are willing to trample on all the rules, with great impunity . .
1 · Reply
Tacto
Tacto Jan. 17 at 12:12 AM
$GERN New Geron corporate presentation just out today. https://s201.q4cdn.com/710325604/files/doc_presentations/2026/Jan/12/Geron-Corporate-Deck-January-2026_FINAL2-1-12-26.pdf Maybe the Europe partnership deal is done, and they're just wrapping up the fine details before making an announcement, otherwise it seems highly unlikely that it wouldn't be mentioned in this presentation... . .
1 · Reply
Tacto
Tacto Jan. 16 at 10:46 PM
$GERN Yup, Aberdeen increased their stake by 60% in Q4, and their estimated average cost per share is $2.11
1 · Reply
smar312
smar312 Jan. 16 at 9:23 PM
$GERN Aberdeen Group just increased share ownership by over 3.5 million. They now hold over 9.5 million shares.
0 · Reply
Srinivas111
Srinivas111 Jan. 16 at 8:44 PM
0 · Reply
ZoeyTanner
ZoeyTanner Jan. 16 at 4:22 PM
$GERN Never hold gains. Investors get tired of excuses and just want out
2 · Reply
foghornL
foghornL Jan. 16 at 3:43 PM
1 · Reply
Tacto
Tacto Jan. 16 at 11:52 AM
$GERN Retail has a minuscule stake, so those stock-dorking idiots can't cover even a tiny fraction of their 70M standard shorts by wresting even the totality of what retail holds, let alone the colossal mass of abusive-naked shorts (counterfeits) they've introduced into the float and are responsible for making good on, and for which they stand to lose their collateral, so they're pretty well f'd, and they know it better than anyone, and it's just a matter of time before they get blown up. Plus, you can bet that I'm not the only retail type whose pocket those assholes can't pick. They've been selling millions of shares to themselves every day, to suppress the stock to delay their demise, but that's just treading water, and they'll soon have to to buy genuine shares on the open market, which will spark a BIG SQUEEZE and cost those ass-clowns several times the utterly-retarded and totally manufactured price you see today. This is the game, and I've got the time, so I'll see it through
1 · Reply
afc2881
afc2881 Jan. 16 at 2:16 AM
$GERN https://www.nature.com/articles/s41375-025-02831-z
0 · Reply
Tacto
Tacto Jan. 16 at 12:56 AM
$GERN At least one of the crime syndicate operators participating in the mammoth stock-distortion scheme is either one of the major shareholders, or one that has the enormous collateral that would have to be put up to then be able to sell gargantuan heaps of abusive-naked shorts (counterfeits) into the float, because it was totally on display all day, for anyone who was watching the four CBOE exchanges, and if you were, you would have observed them putting up bids for many hundreds of thousands at a time on EDGX in particular, on $1.30 and immediately around it, and pouring tons of shares into their own bid throughout the day. Good to be aware that it's all just a giant crock, so as to not be fooled into losing our shares and the game itself... You can watch the top of the book on all four CBOE exchanges via this link below, depending on which of the four tabs you select, BZX (BATX), BYX (BATY), EDGX, and EDGA https://www.cboe.com/us/equities/market_statistics/book/gern/ . .
1 · Reply
Tacto
Tacto Jan. 15 at 11:21 PM
$GERN Stochastic Oversold again, and we saw the same thing just last week. The short retards are trapped, that's why they're flailing around 😆😝 ⌛🌋 . .
0 · Reply
DAWGNuts
DAWGNuts Jan. 15 at 10:41 PM
$GERN people laughed and said the market doesn't look 4 years in advance. The market cap says otherwise. Looks like there will be bigger competition than Luspatercept by that point and they are good at treating RS- patients. 850M is feeling real generous.
1 · Reply
Garp_
Garp_ Jan. 15 at 8:06 PM
$GERN Hat tip to Biopearl. New article out in Nature Magazine on Imetelstat. The most important part of the article, is in the conclusion, it suggests that imetelstat may be "disease-modifying". Here's a summary of the conclusion: "Imetelstat appears to reduce or eliminate dysplastic clones in LR-MDS, leading to improved erythroid function, higher hemoglobin levels, and durable transfusion independence. This suggests potential disease-modifying activity (unlike purely symptomatic treatments like ESAs or luspatercept), by targeting telomerase-dependent clonal progenitor cells."
1 · Reply
ZoeyTanner
ZoeyTanner Jan. 15 at 3:57 PM
$GERN Plenty of blame to go all around, including CEO, who by the way has not improved valuation of this stinker during his tenure. Nothing to show but red ink.
0 · Reply
viking1111
viking1111 Jan. 15 at 3:20 PM
$GERN So difficult for this to uptrend for any length of time. Too sloppy still at this point. Don't blame the shorts or sec or anything else. This has been diluted into oblivion. 600mil float.
0 · Reply
Henry20feb_
Henry20feb_ Jan. 15 at 1:11 PM
$GERN This picture mirrors how real value in biotech actually unfolds: a long, uncertain road, a narrow entry point, and then—if execution clicks—a widening highway of adoption and confidence. Seeing Rytelo framed this way makes it much easier to hold both truths at once: the current commercial friction and the genuine upside embedded in the asset.
1 · Reply
signet01
signet01 Jan. 15 at 12:55 PM
$GERN https://corpgov.law.harvard.edu/2025/12/13/speech-by-commissioner-crenshaw-on-investor-protection-and-market-transparency/
0 · Reply
ZoeyTanner
ZoeyTanner Jan. 15 at 12:54 PM
$GERN The elephant in the room will always be short funds and fleas attached naked shorts to the tune of 70 million shares for massive diluted float. Stuck in perpetuity at 1.33. RIP
0 · Reply
Henry20feb_
Henry20feb_ Jan. 15 at 11:25 AM
$GERN The market is effectively saying: “Show us that Rytelo can sustainably run at $60M+ per quarter and keep climbing.” Once that happens, the probability-weighting shifts from “maybe capped” toward “durable franchise”—and the stock naturally migrates from Bear/Base math toward Base/Bull math (Implied share value ~$3.00–$4.50+). That’s why a few quarters of clean, accelerating demand matter more than almost anything else for Geron’s valuation.
0 · Reply
Tacto
Tacto Jan. 14 at 11:05 PM
$GERN Hugely positive money flow today, and it's just a matter of time.... ⌛🌋 Inflow: 5262.86 Outflow: 3214.55 . .
0 · Reply
afc2881
afc2881 Jan. 14 at 9:22 PM
$GERN Last minute 3m shares traded???
1 · Reply